Join Us for an Investor Update Online with our Acting CEO Scott Flora

Integrum AB (publ), the medical technology company that improves the lives of amputees, cordially invites you to an online investor information session on September 25, 2024, @ 3 pm CEST.

This session will feature our acting CEO Scott Flora, and CFO, Jörgen Svanström, who will share insights into the company’s strategic direction and upcoming initiatives. A warm welcome to join us to learn more about Integrum’s next steps.

When: 25 September 2024 @3pm-3.30pm

Where: https://www.finwire.tv/webcast/integrum/integrum-meeting/

We look forward to seeing you online!

For more information, please contact Scott Flora, CEO, by email scott.flora@integrum.se

Certified Adviser
Carnegie Investment Bank AB (publ) is Certified Adviser.

About Integrum
Integrum is a publicly traded company (Nasdaq First North Growth Market: INTEG B) based outside of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA® Implant System has helped improve the quality of life for hundreds of people who are amputees by directly attaching a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA® Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use in amputees available in the U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/.